Tasly Pharmaceutical Group (600535.SHG) Q3 2025 Earnings

15AugConfirmed
Q4 2024
Q1 2025
Q2 2025
Q3 2025
0.12
0.16
0.21
0.25

Details

Expected EPS
0.25055155875
Actual EPS
0.23050743405000002
Surprise EPS
-0.02
Surprise Percent
+8%

Description

Tasly Pharmaceutical Group (600535.SHG) has reported earnings of 0.23050743405000002 per share for Q3 2025.

0 Comments

Share your thoughts